Is adult attention-deficit hyperactivity disorder being overdiagnosed?

Canadian Journal of Psychiatry

Volumn 60, Issue 7, 2015, Pages 324-328

  Paris, Joel ^a,b   Bhat, Venkat ^b   Thombs, Brett ^b,c  

^a MCGILL UNIVERSITY   (Canada)

^b MCGILL UNIVERSITY   (Canada)

^c MCGILL UNIVERSITY   (Canada)

Author keywords

Adult attention deficit hyperactivity disorder; Overdiagnosis

Indexed keywords

ADULT; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; DIAGNOSTIC ERROR; HUMAN;

ADULT; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; DIAGNOSTIC ERRORS; HUMANS;

EID: 84936991684     PISSN: 07067437     EISSN: 14970015     Source Type: Journal    
DOI: 10.1177/070674371506000705     Document Type: Review

References (47)

1. Moynihan R, Doust J, Henry D. Preventing over-diagnosis: how to stop harming the healthy. BMJ. 2012;344:e3502.
2. Welch HG, Schwartz L, Woloshin S. Overdiagnosed: making people sick in the pursuit of health. Boston (MA): Beacon Press; 2011.
3. Welch HG, Frankel BA. Likelihood that a woman with screen detected breast cancer has had her "life saved" by that screening. Arch Intern Med. 2011;171:2043-2046.
4. Welch HG, Black WC. Over-diagnosis in cancer. J Natl Cancer Inst. 2010;102:605-613.
5. Weyers W. The "epidemic" of melanoma between under- and overdiagnosis. J Cutan Pathol. 2012;39:9-16.
6. Black WC. Advances in radiology and the real versus apparent effects of early diagnosis. Eur J Radiol. 1998;27:116-122.
7. Davies L, Welch HG. Increasing incidence of thyroid cancer in the United States, 1973-2002. JAMA. 2006;295:2164-2167.
8. Moffitt TE, Caspi A, Taylor A, et al. How common are common mental disorders? Evidence that lifetime prevalence rates are doubled by prospective versus retrospective ascertainment. Psychol Med. 2009;40:899-909.
9. Paris J. The intelligent clinician's guide to DSM-5. New York (NY): Oxford University Press; 2013.
10. Lange KW, Reichl S, Lange KM, et al. The history of attention deficit hyperactivity disorder. Atten Def Hyp Disord. 2010;2:241-255.
11. Hechtman L. Prospective follow-up studies of ADHD: helping establish a valid diagnosis in adults. J Amer Acad Child Adolesc Psychiatry. 2011;50:533-536.
12. American Psychiatric Association (APA). Diagnostic and statistical manual of mental disorders. 5th ed. Washington (DC): APA; 2013.
13. Kessler RC, Adler L, Barkley R, et al. The prevalence and correlates of adult ADHD in the United States: results from the National Comorbidity Survey replication. Am J Psychiatry. 2006;163:716-723.
14. Batstra L, Frances AJ. DSM-5 further inflates attention deficit hyperactivity disorder. J Nerv Ment Dis. 2012;200:486-488.
15. Asherson P, Moncrieff J, Timini S. Is ADHD a valid diagnosis in adults? BMJ. 2010;340:736-737.
16. Singh I. Beyond polemics: science and ethics of ADHD. Nat Rev Neurosci. 2008;9:957-963.
17. Simon V, Czobor P, Bálint S, et al. Prevalence and correlates of adult attention-deficit hyperactivity disorder: meta-analysis. Br J Psychiatry. 2009;194:204-211.
18. Sciutto MJ, Eisenberg M. Evaluating the evidence for and against the over-diagnosis of ADHD. J Atten Disord. 2007;11:106-113.
19. Faraone SV, Sergeant J, Gillberg C, et al. The worldwide prevalence of attention deficit hyperactivity disorder. J Amer Acad Child Adolesc Psychiatry. 2000;39:182-193.
20. Zimmerman M, Galione J. Psychiatrists' and nonpsychiatrist physicians' reported use of the DSM-IV criteria for major depressive disorder. J Clin Psychiatry. 2010;71:235-238.
21. Zimmerman M, Galione JN, Ruggero CJ, et al. Screening for bipolar disorder and finding borderline personality disorder. J Clin Psychiatry. 2010;71:1212-1217.
22. Olfson M, Blanco C, Wang S, et al. Trends in office based treatment of adults with stimulants in the United States. J Clin Psychiatry. 2013;74:43-50.
23. McCarthy S, Wilton L, Murray ML, et al. The epidemiology of pharmacologically treated attention deficit disorder in children, adolescents and adults in UK primary care. BMC Pediatrics. 2012;12:78-84.
24. Leung AK, Lemay JF. Attention deficit hyperactivity disorder: an update. Adv Thers. 2003;20:305-318.
25. Bishop DVM, Rutter ML. Neurodevelopmental disorders: conceptual approaches. In: Rutter M, Bishop D, Pine D, et al, editors. Rutter's child and adolescent psychiatry. Oxford (GB): Blackwell; 2008. p 32-41.
26. Posner MI. Attentional networks and consciousness. Front Psychol. 2012;3:64-70.
27. Cumyn L, French L, Hechtman L. Comorbidity in adults with attention-deficit hyperactivity disorder. Can J Psychiatry. 2009;54:673-683.
28. Schacter DL. Searching for memory. New York (NY): Basic Books; 1996.
29. Franke B, Faraone SV, Asherson P, et al. The genetics of attention deficit/hyperactivity disorder in adults, a review. Mol Psychiatry. 2012;17:960-987.
30. Woods SP, Lovejoy DW, Ball JD. Neuropsychological characteristics of adults with ADHD: a comprehensive review of initial studies. Clin Neuropsychol. 2002;16:12-34.
31. Conners C, March J, Erhardt D, et al. Assessment of attention-deficit disorders. J Psychoed Assess. 1996;32:186-205.
32. McGee RA, Clark SE, Symons DK. Does the Conners' Continuous Performance Test aid in ADHD diagnosis? J Abnorm Child Psychol. 2000;28:415-424.
33. Barkley RA, Murphy KR, Fischer M. ADHD in adults: what the science says. New York (NY): Guilford Press; 2010.
34. Wilens TE, Morrison NR, Prince J. An update on the Pharmacotherapy of attention-deficit/hyperactivity disorder in adults. Expert Rev Neurother. 2011;11:1443-1465.
35. Castellas X, Ramos-Quiroga JA, Bosch R, et al. Amphetamines for attention deficit hyperactivity disorder (ADHD) in adults. Cochrane Database Syst Rev. 2011;(6):CD007813.
36. Kooij SJ, Bejerot S, Blackwell A. European consensus statement on diagnosis and treatment of adult ADHD: The European Network Adult ADHD. BMC Psychiatry. 2010;10:67.
37. Mészáros M, Czobor P, Bálint S, et al. Pharmacotherapy of adult ADHD: a meta-analysis. Int J Neuropsychopharmacol. 2009;12(8):1137-1147.
38. Surman CBH, Hammerness PG, Pion K, et al. Do stimulants improve functioning in adults with ADHD? A review of the literature. Eur Neuropsychopharmacol. 2013;23:528-533.
39. Franke B, Faraone SV, Asheron P, et al. Long-term efficacy and safety of treatment with stimulants and atomoxetine in adult ADHD: a review of controlled and naturalistic studies. Eur Neuropsychopharmacol. 2012;23:508-527.
40. Rapoport JL, Buchsbaum MS, Zahn TP, et al. Dextroamphetamine: cognitive and behavioral effects in normal prepubertal boys. Science. 1978;199:560-563.
41. Smith ME, Farah MJ. Are prescription stimulants "smart pills"? The epidemiology and cognitive neuroscience of prescription stimulant use by normal healthy individuals. Psychol Bull. 2011;137:717-741.
42. Wilens TE, Adler LA, Adams J. Misuse and diversion of stimulants prescribed for ADHD: a systematic review of the literature. J Am Acad Child Adolesc Psychiatry. 2008;47:21-31.
43. Shah PJ, Morton MJS. Adults with attention-deficit hyperactivity disorder diagnosis or normality? Br J Psychiatry. 2013;203:317-319.
44. Lewandowsi L, Cohen J, Lovett BJ. Effects of extended time allotments on reading comprehension performance of college students with and without learning disabilities. J Psychoeduc Assess. 2013;31:326-336.
45. Conrad P, Potter D. From hyperactive children to ADHD adults: observations on the expansion of medical categories. Soc Probl. 2000;47:559-582.
46. Greely H, Campbell P, Sahakian B, et al. Towards responsible use of cognitive-enhancing drugs by the healthy. Nature. 2008;456:702-705.
47. Thomas R, Mitchell GK, Batstra L. Attention-deficit/hyperactivity disorder: are we helping or harming? BMJ. 2013;347:f6172.